meyers & flowers appointed to testosterone litigation
Partners Brian Perkins and Pete Flowers are appointed key representatives in the Testosterone Replacement Therapy Products Liability Litigation. Brian Perkins was appointed to the Plaintiffs Committee in multidistrict litigation (MDL) 2545 titled In re: Testosterone Replacement Therapy Products Liability and Peter Flowers was appointed the lead in the Cook County State Court Litigation for Testosterone.
Meyers & Flowers is committed to represent the men injured by testosterone medications and are working to investigate and prosecute the claims of men who suffered heart attacks, strokes, pulmonary embolisms, and blood clots as a result of taking testosterone.
In January 2014, the U.S. Food and Drug Administration (FDA) announced that it was investigating the safety of testosterone medications and their potential relationship to heart attacks and strokes. The FDA will hold a conference in September 2014 to address these issues.
The labeling for all testosterone medications was changed and broadened by the FDA on June 19, 2014 concerning the risks of blood clots. Prior labeling only warned about blood clots in the legs as a result of polycythemia. The new labeling warns about blood clots in the legs and lungs generally and not as related to any specific condition other than testosterone use.
Lawsuits filed across the nation are being coordinated in a multi-district litigation (In Re: Testosterone Replacement Therapy Products Liability Litigation, 1:14-cv-01748) before Judge Matthew Kennelly in the Northern District of Illinois.
Meyers & Flowers is a national leader in medical device/pharmaceutical litigation. For more information regarding Testosterone Therapy Products Litigation or other medical device/pharmaceutical litigation, feel free to contact the firm.